Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Comment by JDavenporton Jun 10, 2022 12:39pm
172 Views
Post# 34747505

RE:RE:RE:RE:RE:RE:RE:RE:RE:The Roadshows. Question Everything, Including Nothing.

RE:RE:RE:RE:RE:RE:RE:RE:RE:The Roadshows. Question Everything, Including Nothing.
I'm not flipping, Aarcor. I still support Bioasis, xB3 and the shareholders. I still support DrDR but I have concerns about aspects of her management practices and her abilities to get good deals.
 
The deals I have problems with are Prothena, Neuramedy and, to a degree, Chiesi. I agree with you. As I stated yesterday, it's time for some news out of Chiesi. We have never had any indication that Chiesi has even started work on any of the four LSDs. That is not acceptable. No argument with you on that. Chiesi milestone payment sources were described as "developmental, regulatory and commercial." Does the lack of developmental milestone payments indicate that no development has been done? I could write a book on that deal.
 
Also, we don't have any information about the Aposense, Oxyrane, Janssen, and Daiichi Sankyo agreements. And I criticize DrDR for the lack of disclosure in several areas, and disclosures that are clumsy attempts to satisfy disclosure needs without telling us much of anything. 
 
But I'm not unique in my views. I talk to a lot of people. DrDR is in a hard spot. Bioasis doesn't need any more cheap deals. Secrecy and nondisclosure are big problems. Bioasis borrowed money for internal programs and we've heard nothing about work being done on the Bioasis pipeline. Being offshore doesn't help her, nor does being CEO of Carina. 
 
She has very little wiggle room and roadshows won't help, other than to show her that Canadians can be very polite while plotting her ouster. That can change with a good deal that has some real value optics.
 
I do not advocate for her ouster but her ouster could prevent bad deals like a creepy equity financing at the hands of Ladenburg Thalmann or another cheap partnership deal. But then, maybe she has good deals in the offing. I am pretty sure of one thing, the roadshows will be all sweetness and light with little substance. Too smarmy by half, my guess.
 
I took you off ignore, Aarcor, mostly because you do present a little argument, not just bellicose anti-everything brain-dead prattle like some others. The readers here are too smart to be bothered with reading the same nonsense in every post.
 
jd
 
<< Previous
Bullboard Posts
Next >>